Grail (NASDAQ:GRAL) Trading Down 7.4% – Here’s Why

Grail, Inc. (NASDAQ:GRAL) traded down 7.4% on Tuesday . The stock traded as low as $18.14 and last traded at $18.21. 127,209 shares changed hands during mid-day trading, a decline of 67% from the average session volume of 383,007 shares. The stock had previously closed at $19.67.

Analyst Upgrades and Downgrades

GRAL has been the subject of a number of recent research reports. Guggenheim started coverage on Grail in a report on Thursday, October 17th. They set a “neutral” rating for the company. Morgan Stanley began coverage on Grail in a research report on Wednesday, November 27th. They issued an “equal weight” rating and a $16.00 price target for the company. Finally, Wolfe Research initiated coverage on shares of Grail in a report on Friday, November 15th. They set a “peer perform” rating on the stock.

Grail Trading Down 1.2 %

The business has a 50-day moving average price of $17.80.

Insider Activity

In other Grail news, CFO Aaron Freidin sold 30,452 shares of Grail stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $14.02, for a total value of $426,937.04. Following the sale, the chief financial officer now owns 268,277 shares of the company’s stock, valued at approximately $3,761,243.54. The trade was a 10.19 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Robert P. Ragusa sold 123,454 shares of Grail stock in a transaction that occurred on Tuesday, October 15th. The stock was sold at an average price of $14.02, for a total transaction of $1,730,825.08. Following the completion of the sale, the chief executive officer now directly owns 612,661 shares in the company, valued at $8,589,507.22. This trade represents a 16.77 % decrease in their position. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Grail stock. Douglas Lane & Associates LLC purchased a new position in Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 169,977 shares of the company’s stock, valued at approximately $3,034,000. Douglas Lane & Associates LLC owned 0.51% of Grail at the end of the most recent reporting period.

About Grail

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.